205 related articles for article (PubMed ID: 3034102)
1. Effect of structural modification at carbon atom 1 of leukotriene B4 on the chemotactic and metabolic response of human neutrophils.
Clancy RM; Dahinden CA; Hugli TE
Anal Biochem; 1987 Mar; 161(2):550-8. PubMed ID: 3034102
[TBL] [Abstract][Full Text] [Related]
2. Chemotaxis of human neutrophils and eosinophils towards leukotriene B4 and its 20-w-oxidation products in vitro.
Czarnetzki BM; Rosenbach T
Prostaglandins; 1986 May; 31(5):851-8. PubMed ID: 3014612
[TBL] [Abstract][Full Text] [Related]
3. Stereospecificity of leukotriene B4 and structure-function relationships for chemotaxis of human neutrophils.
Dahinden CA; Clancy RM; Hugli TE
J Immunol; 1984 Sep; 133(3):1477-82. PubMed ID: 6086758
[TBL] [Abstract][Full Text] [Related]
4. Specific inhibition of leukotriene B4 (LTB4)-induced neutrophil emigration by 20-hydroxy LTB4: implications for the regulation of inflammatory responses.
Pettipher ER; Salter ED; Breslow R; Raycroft L; Showell HJ
Br J Pharmacol; 1993 Sep; 110(1):423-7. PubMed ID: 8220903
[TBL] [Abstract][Full Text] [Related]
5. Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils.
Sperling RI; Benincaso AI; Knoell CT; Larkin JK; Austen KF; Robinson DR
J Clin Invest; 1993 Feb; 91(2):651-60. PubMed ID: 8381824
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of 20-trifluoromethyl leukotriene B4 on human neutrophil functions.
Tsai BS; Keith RH; Villani-Price D; Haack RA; Bauer RF; Leonard R; Abe Y; Nicolaou KC
Prostaglandins; 1989 Feb; 37(2):287-302. PubMed ID: 2543037
[TBL] [Abstract][Full Text] [Related]
7. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
Tsai BS; Keith RH; Villani-Price D; Haack RA; Djuric SW
J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959
[TBL] [Abstract][Full Text] [Related]
8. The effect of 20-trifluoromethyl leukotriene B4 on neutrophil functional responses.
Nilsson E; Gyllenhammar H; Lerner R; Palmblad J; Ringertz B
Scand J Immunol; 1991 Apr; 33(4):357-63. PubMed ID: 1850167
[TBL] [Abstract][Full Text] [Related]
9. Oxidation of 20-hydroxyleukotriene B4 to 20-carboxyleukotriene B4 by human neutrophil microsomes. Role of aldehyde dehydrogenase and leukotriene B4 omega-hydroxylase (cytochrome P-450LTB omega) in leukotriene B4 omega-oxidation.
Sumimoto H; Minakami S
J Biol Chem; 1990 Mar; 265(8):4348-53. PubMed ID: 2155225
[TBL] [Abstract][Full Text] [Related]
10. 20-Hydroxy- and 20-carboxy-leukotriene (LT) B
Archambault AS; Poirier S; Lefebvre JS; Robichaud PP; Larose MC; Turcotte C; Martin C; Provost V; Boudreau LH; McDonald PP; Laviolette M; Surette ME; Flamand N
J Leukoc Biol; 2019 Jun; 105(6):1131-1142. PubMed ID: 30676680
[TBL] [Abstract][Full Text] [Related]
11. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF
J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400
[TBL] [Abstract][Full Text] [Related]
12. Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: impact upon leukotriene B4- and 12(R)-HETE-mediated events.
Fretland DJ; Anglin CP; Bremer M; Isakson P; Widomski DL; Paulson SK; Docter SH; Djuric SW; Penning TD; Yu S
Inflammation; 1995 Apr; 19(2):193-205. PubMed ID: 7601505
[TBL] [Abstract][Full Text] [Related]
13. Structural requirements for chemotactic activity of leukotriene B4 (LTB4).
Hoffstein ST; Manzi RM; Razgaitis KA; Bender PE; Gleason J
Prostaglandins; 1986 Feb; 31(2):205-15. PubMed ID: 3008215
[TBL] [Abstract][Full Text] [Related]
14. Activation of neutrophil chemotaxis by leukotriene B4 and 5-hydroxyeicosatetraenoic acid in chronic inflammatory bowel disease.
Nielsen OH; Elmgreen J
Scand J Clin Lab Invest; 1987 Oct; 47(6):605-11. PubMed ID: 2823370
[TBL] [Abstract][Full Text] [Related]
15. Effect of a leukotriene B4 receptor antagonist on leukotriene B4-induced neutrophil chemotaxis in cavine dermis.
Fretland DJ; Widomski DL; Zemaitis JM; Djurić SW; Shone RL
Inflammation; 1989 Oct; 13(5):601-5. PubMed ID: 2553605
[TBL] [Abstract][Full Text] [Related]
16. Effects of metabolites of leukotriene B4 on human neutrophil migration and cytosolic calcium levels.
Powell WS; Rokach J; Khanapure SP; Manna S; Hashefi M; Gravel S; Macleod RJ; Falck JR; Bhatt RK
J Pharmacol Exp Ther; 1996 Feb; 276(2):728-36. PubMed ID: 8632343
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene B4-activated human endothelial cells promote transendothelial neutrophil migration.
Nohgawa M; Sasada M; Maeda A; Asagoe K; Harakawa N; Takano K; Yamamoto K; Okuma M
J Leukoc Biol; 1997 Aug; 62(2):203-9. PubMed ID: 9261334
[TBL] [Abstract][Full Text] [Related]
18. Characterization of leukotriene B3: comparison of its biological activities with leukotriene B4 and leukotriene B5 in complement receptor enhancement, lysozyme release and chemotaxis of human neutrophils.
Lee TH; Sethi T; Crea AE; Peters W; Arm JP; Horton CE; Walport MJ; Spur BW
Clin Sci (Lond); 1988 May; 74(5):467-75. PubMed ID: 2836122
[TBL] [Abstract][Full Text] [Related]
19. Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982.
Jackson WT; Boyd RJ; Froelich LL; Mallett BE; Gapinski DM
J Pharmacol Exp Ther; 1992 Dec; 263(3):1009-14. PubMed ID: 1335049
[TBL] [Abstract][Full Text] [Related]
20. Influence of standard and novel LTB4 analogs on human neutrophil chemotaxis measured by the multiwell cap assay.
Psychoyos S; Uziel-Fusi S; Bhagwat S; Morrissey MM
J Immunol Methods; 1989 Nov; 124(2):189-96. PubMed ID: 2557367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
